STERIS plc
215.09USD
-3.3500 (-1.53%)
Revenue
| (USD) | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| FY | 4.5B | 5.1B | 5.5B | 5.9B | 6.4B | 6.8B |
| Q1 | 1.1B | 1.2B | 1.3B | 1.4B | 1.5B | — |
| Q2 | 1.1B | 1.2B | 1.3B | 1.5B | 1.6B | — |
| Q3 | 1.1B | 1.3B | 1.4B | 1.5B | 1.6B | — |
| Q4 | 1.3B | 1.4B | 1.5B* | 1.6B* | — | — |
Revenue
| (USD) | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| FY | 1.07 | 3.81 | 6.20 | 7.93 | 11.17 | 12.25 |
| Q1 | 1.10 | 1.25 | 1.46 | 1.79 | 2.04 | — |
| Q2 | -3.15 | 1.16 | 1.51 | 1.94 | 2.68 | — |
| Q3 | 1.24 | 1.42 | 1.75 | 1.96 | 2.81 | — |
| Q4 | 1.88 |
Fiscal period: Reported, Estimated. Reported figures: SEC filings (EDGAR). Estimates are sell-side consensus for periods that have not reported. Cells marked * were synthesized from the annual filing less the year-to-date figures, because the quarter was not filed on its own. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.
| -.010 |
| 1.47* |
| 2.23* |
| — |
| — |